Market Trends

How to Manage Risk in Speculative Biotech Stocks

April 23, 2018

author:

How to Manage Risk in Speculative Biotech Stocks

When most companies go public, they are somewhat mature. They typically have earnings and cash flow.

Tech company initial public offerings, or IPOs, are a bit different. The companies are often not yet profitable.

And biotech IPOs are a special animal altogether. Not only are the companies usually not profitable, but most of the time they don’t even have a product on the market yet.

For example, last Thursday, Surface Oncology (Nasdaq: SURF) had its IPO, raising more than $119 million. The company is developing antibodies that target tumors. It has one drug in Phase 1 trials – the earliest stage of human trials – and six drugs that have not yet entered clinical trials.

So investors buying Surface Oncology are essentially hoping that one day it will get a product approved and on the market, and that said product will sell well.

When things work for these small cap biotechs, it can be insanely lucrative.

Take Pharmacyclics, for example.

The company, focused on treating cancer, went public in 1995, offering 2.15 million shares at $12 per share and raising a little more than $25 million.

It wasn’t until 14 years later that Pharmacyclics conducted its first human trials of Ibrutinib, which went on to become the company’s first FDA-approved product in 2014 and a blockbuster drug.

The following year, AbbVie (NYSE: ABBV) acquired Pharmacyclics for $21 billion.

If you had bought Pharmacyclics on December 7, 2009, after the company presented positive results from a Phase 1 study, you could have bought the stock for $2.35. A little more than five years later, the company announced it was being acquired and you could have sold it for $230.48.

Of course, you would have had to hold on to a very speculative company for more than five years to do it. But even if you had sold pieces of the position off over the years and were left with a fraction of the original position, you would have done extremely well.

Pharmacyclics is the exception though, not the rule. Most early-stage biotech companies never have that kind of success. Many never get a drug on the market.

In fact, a drug entering human trials has about only a 1 in 10 chance of being approved. So it makes sense that the rewards need to be large to take on that kind of risk.

Since these stocks can be very speculative, there are a few things you can do to lower your risk.

  1. Place a trailing stop. I recommend using a 25% trailing stop on most trading positions. That means you raise the stop as the stock moves higher. That can help limit your losses if things go wrong.
  2. Position size accordingly. I recommend never putting more than 4% of your risk capital into any one position. That way, if you get stopped out for a 25% loss, you’ve lost only 1% of your total capital.
  3. Keep an eye on catalysts. Small biotech stocks don’t often react to earnings reports like most stocks do. But they can fly around after the release of clinical trial data or a presentation at an important conference. Be aware of when data is coming out or when a company is scheduled to present at a conference so you can pay attention to how the stock responds to news. Companies will usually issue press releases mentioning the dates they’re presenting at conferences.

Specific dates for clinical data releases are usually not announced ahead of time. Rather, companies will give a rough time frame for the data release, such as “first quarter of the year.”

You can hit some big home runs in the biotech sector, but you need to manage your risk when trading these stocks.

If you handle your risk properly, you’ll be able to take more big swings and hit one of those portfolio-altering gains.

Good investing,

Marc

48 Comments
  1. 755039

    633608em3scbzf09

  2. 755039

    633608

  3. 615265

    701455

  4. 304179

    435544

  5. 474618

    4aftydfurr05qe64ovsdf4wer5xylped65uxhn5c

  6. 474618

    635878

  7. 385837

    492662

  8. 269512

    529087

  9. 193795

    869146

  10. 541305

    129911

  11. 822647

    241048

  12. 151638

    206319

  13. 497530

    217764

  14. 448284

    785629

  15. 686327

    199730

  16. 901877

    796784

  17. 777690

    354657

  18. 918949

    754457

  19. 195059

    107998

  20. 848522

    598265

  21. 605120

    172317

  22. 169143

    628444

  23. 689694

    871512

  24. 873634

    367967

  25. 756467

    548017

  26. 525977

    852725

  27. 945252

    909681

  28. 479679

    555775

  29. 205593

    914247

  30. 843809

    542841

  31. 677037

    157322

  32. 671318

    540411

  33. 131394

    218712

  34. 570610

    215115

  35. 161787

    209592

  36. 415914

    932304

  37. 805223

    951101

  38. 828848

    490592

  39. 602107

    671212

  40. 318037

    610662

  41. 812619

    113142

  42. 593712

    999647

  43. 988618

    444273

  44. 574494

    109055

  45. 309635

    347031

  46. 752726

    4quxfh4peq

  47. 752726

    790982

  48. 752726

    ycerycm31lw7ibikufx943150w6pugqce46syfo3d

Leave a comment

Your email address will not be published.